Friday, November 3, 2023 - 08:30 to 17:00
You are here
Home- Overview
- Keynote Speakers
- Agenda
- Sponsors
- Location
November
03
Friday
- 8:30 AM to 5:00 PM
- Vantage Venue, 150 King Street W
27th floor
We are pleased to invite you to the 4th Annual Lung Oncology Research Day. This annual event celebrates our achievements in clinical and translational research. The purpose of this conference is for the lung group to share, update, and discuss ongoing lung cancer research across the entire multi-disciplinary spectrum with participation from researchers, clinicians, and trainees.
This year, Research Day will be held on Friday, November 03, 2023 at the Vantage Venues, 27th floor located at 150 King Street West in downtown Toronto.
Trainees (i.e., clinical fellows, postdoctoral fellows,& residents) currently working under the supervision of a Principal Investigator at the lung site are invited to submit an abstract for an oral presentation or a poster.
Abstracts submitted to international or national meetings over the past year are welcome. There will be Awards for the best clinical and basic science presentations.
Registration is free and we encourage everyone to register as soon as possible.
If you plan to submit an abstract, please register and then email your abstract to Fatemeh Zaeimi, Fatemeh.Zaeimi@uhn.ca
Please mark your calendars for November 03, 2023 and we look forward to seeing you there!
IMPORTANT DATES:
Abstract Submission Deadline: Friday, September 29, 2023 at 4:00 p.m. (no late submissions will be accepted)
Registration Closes: Friday, October 27, 2023 at 4:00 pm.
Online registration is mandatory for all presenters and general attendees.
Keynote Speakers
Kurt A. Schalper, M.D., Ph.D.
Associate Professor of Pathology and Medicine (Medical Oncology)
Yale School of Medicine
Director Translational Immuno-oncology Laboratory
Yale Cancer Center
Kurt A. Schalper, M.D., Ph.D., is an associate professor in the Department of Pathology and Medicine at Yale School of Medicine. Recently, Dr. Schalper was appointed to lead the Translational Immuno-Oncology Laboratory (T.I.L.) in the Yale Cancer Center. Dr. Schalper’s research is focused on understanding the immunobiology of human solid tumors and developing molecular biomarkers for prediction of response or resistance to therapies. More recent and future scientific interests include the evaluation and clinical impact of tumor immune heterogeneity and editing.
Colin Collins, Ph.D.
Professor, University of British Columbia
Senior Scientist and Director
Laboratory for Advanced Genome Analysis
Vancouver Prostate Centre
Colin Collins, Ph.D., is a tenured professor at the University of British Columbia. Dr. Collins specializes in translational cancer genomics and the applications of integrative analysis of multi-omics data to discovery and functional studies. Based at the Vancouver Prostate Centre, where he leads the Laboratory for Advanced Genome Analysis, Dr. Collins’ lab focuses on translational cancer genomics to study mechanisms of treatment resistance for the benefit of precision oncology.
4th Annual Toronto Lung Oncology Research Day Agenda, Friday November 3, 2023
8:30 AM-9:00 AM
Registration and Breakfast
9:00 AM-9:10 AM
Welcome and Opening Remarks
Dr. Marc de Perrot
Dr. Marc de Perrot
9:10 AM–10:10 AM
Session I – Personalized Therapy, Better Staging & More Precise Immunotherapy Treatment for NSCLC
Dr. Ming Tsao
Title: TBA
Dr. Ming Tsao
Title: TBA
Dr. Roger Hsu
Title: Molecular Alterations in Non-Small cell Lung Cancer arising in Emphysematous and Fibrotic Lungs
Dr. Phedias Diamandis
Title: AI in pathology and its application
15’ Q & A Panel Discussion
10:10AM-10:25AM
Coffee Break
10:25 AM-11:20 AM
Dr. Benjamin Lok
Title: TBA
Title: TBA
Dr. Andrew Hope
Title: TBA
Dr. Mercedes Herrera
Title: TBA
11:20AM-12:10PM
Keynote Speaker I: Dr. Kurt Schalper, Director, Translational Immuno-oncology Laboratory, Yale Cancer Center
Title: TBA
Title: TBA
12:10PM-1:00PM
Lunch
1:00 PM-2:05 PM
Session II – Updates on Clinical Trials and New Treatments
Dr. Frances Sheppard
Title: Pre-op versus Post- op Therapy in Surgically Resectable NSCLC
Dr. Jillian Tsai
Title: Consolidation use of radiotherapy to block oligoprogression
Dr. Hannah Bacon
Title: Association of Artificial Intelligence-Screened Interstitial Lung Disease with Radiation Pneumonitis and Mortality in Locally Advanced Non-Small Cell Lung Cancer
Dr. Janet Papadakos
Title: Lung educational needs assessment
15’ Q & A Panel Discussion
2:05 PM-2:20 PM
Coffee Break
2:20 PM-3:10 PM
Keynote Speaker II: Dr. Colin Collins, Professor, Senior Scientist and Director, Laboratory for Advanced Genome Analysis, University of British Columbia
Title: TBA
Title: TBA
3:10 PM-3:25 PM
Coffee Break
3:25 PM-4:30 PM
Dr. Jamie Feng
Title: Effect of TP53 co-mutation in non-small cell lung cancer (NSCLC) with driver mutations
Title: Effect of TP53 co-mutation in non-small cell lung cancer (NSCLC) with driver mutations
Dr. Rayjean Hung
Title: TBA
Dr. Patrick Rogalla
Title: To learn outweighs designing: Deep learning image reconstruction in CT
Dr. Marc de Perrot
Title: TBA
15’ Q & A Panel Discussion
4:30 PM-5:00 PM
Awards Ceremony and Recognition
